McNeice Paul Francis sold $6K of AMWL

McNeice Paul Francis (Chief Accounting Officer) sold 653 shares of American Well Corp (AMWL) at $9.33 on 2026-07-01.

Original reporting
SEC EDGAR · McNeice Paul Francis
Published Jul 1, 2026, 9:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 1, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMWL
Neutral
medium confidence
Mentioned
$AMWL
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMWLNeutralLow
01

Why it matters

This provides a fresh datapoint on insider behavior (CFO selling), but it does not include any new business, financial, or regulatory development.

02

Market read

Traders may note insider selling, but the transaction’s small size suggests limited tradable impact absent other catalysts.

03

What to watch

No 10b5-1 plan is indicated, but insider sales can still be scheduled outside 10b5-1; the disclosed dollar amount is very small, reducing signal-to-noise.

Relevance 3/10Novelty 3/10Timing: filed 2026-07-01 (after-hours) for an insider sale dated 2026-07-01

Background

The article is an SEC Form 4 insider transaction disclosure for American Well Corp (AMWL).

Company-level read

Ticker impact

$AMWLNeutralMedium confidence
Context

AMWL insider Form 4 shows CFO McNeice Paul Francis sold 653 shares on 2026-07-01 at $9.33, totaling ~$6.1K.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and minor.

Evidence & confidence

The filing is a primary insider transaction, but the disclosed value (~$6.1K) is small relative to typical AMWL trading/market cap, and there is no accompanying operational or guidance change.

Market effects

No clear sector read-through from a small CFO sale without additional company-specific catalysts.

None.

None.

Counterpoint

The sale may be for personal liquidity/tax needs rather than a bearish signal, especially since the filing does not provide context on motives.

Key entities

  • American Well Corp

    Subject of the Form 4 insider transaction disclosure.

  • McNeice Paul Francis

    Chief Accounting Officer who sold 653 shares on 2026-07-01.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMWLMed

American Well Corp (AMWL) Q3 2026 Earnings Call Highlights: Revenue Beat, Raised Guidance

American Well Corp (AMWL) reported Q3 2026 revenue of $49M, down 12.9% YoY. Subscription revenue fell 22.5% due to churn. Platform visits dropped 30.5% YoY. The VA letter of intent is non-binding, and the DHA contract conversion is pending. CEO Dr. Ido Schoenberg expressed optimism about negotiations and potential growth opportunities. The company expects Q4 adjusted EBITDA breakeven and raised guidance.

$AMWLMedAI 8/10

What American Well (AMWL) Said on Its Q3 Earnings Call

Amwell (AMWL) reported Q3 earnings with virtual primary care visits up 41% YoY, but total platform visits down 30.5%. Gross profit was $26M with a 53% margin. Q4 revenue is forecasted at $48M-$50M, with adjusted EBITDA expected to break even or turn positive. The company raised its full-year 2026 outlook, now expecting revenue of $204M-$206M and a reduced adjusted EBITDA loss. Amwell also discussed potential government contracts, including a nonbinding letter of intent from the VA.

$AMWLHigh

American Well Corp (AMWL): AMWELL® ANNOUNCES RESULTS FOR THE third QUARTER 2026

American Well Corp (AMWL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMWELL® ANNOUNCES RESULTS FOR THE third QUARTER 2026 BOSTON, November 3 , 2026 –Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the third quarter ended September 30,

$AMWLMedAI 8/10

American Well (AMWL) Q2 2026 Earnings Call Transcript

American Well (AMWL) reported Q2 2026 revenue of $52 million, down 26.6% year over year, with subscription revenue of $25.7 million and AMG revenue of $24.4 million. Adjusted EBITDA loss was $1.15 million and net loss was $9.6 million. Full-year guidance was narrowed to $200-$205 million revenue and improved adjusted EBITDA loss to $9-$7 million. The Defense Health Agency issued an intent to award a sole-source contract.